GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » scPharmaceuticals Inc (FRA:2SX) » Definitions » Current Accrued Expense

scPharmaceuticals (FRA:2SX) Current Accrued Expense : €5.68 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is scPharmaceuticals Current Accrued Expense?

scPharmaceuticals's Current Accrued Expense for the quarter that ended in Mar. 2024 was €5.68 Mil.

scPharmaceuticals's quarterly Current Accrued Expense increased from Sep. 2023 (€3.58 Mil) to Dec. 2023 (€3.92 Mil) and increased from Dec. 2023 (€3.92 Mil) to Mar. 2024 (€5.68 Mil).

scPharmaceuticals's annual Current Accrued Expense declined from Dec. 2021 (€2.51 Mil) to Dec. 2022 (€2.39 Mil) but then increased from Dec. 2022 (€2.39 Mil) to Dec. 2023 (€3.92 Mil).


scPharmaceuticals Current Accrued Expense Historical Data

The historical data trend for scPharmaceuticals's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

scPharmaceuticals Current Accrued Expense Chart

scPharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only 2.15 2.28 2.51 2.39 3.92

scPharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.44 2.35 3.58 3.92 5.68

scPharmaceuticals Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


scPharmaceuticals Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of scPharmaceuticals's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


scPharmaceuticals (FRA:2SX) Business Description

Traded in Other Exchanges
Address
2400 District Avenue, Suite 310, Burlington, MA, USA, 01803
scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on pharmaceutical products in the cardiovascular and infectious disease therapeutic areas. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

scPharmaceuticals (FRA:2SX) Headlines

No Headlines